Regulation & Compliance

New data reveals Vermont's long-term care costs are among the nation's highest, forcing families and policymakers to confront a growing financial crisis.

Great Hill Partners appoints AI head Leland Lockhart, signaling a critical trend where specialized tech leadership becomes the new frontier for value creation.

A new national agreement gives thousands of U.S. hospitals streamlined access to Nanosonics' trophon3, aiming to elevate patient safety standards.

A new study aims to confirm a novel immunotherapy's dramatic results in colorectal cancer, offering hope for patients with limited treatment options.

Forum Investment Group hires Ares vet Grant Turner in a strategic bid to scale its 1031 exchange platform and capture the booming tax-advantaged market.

Snack giant Our Home unveils a strategic pivot at Expo West, doubling down on protein and avocado oil to capture the modern, health-conscious consumer.

Halia Therapeutics is betting on a novel target to fight chronic inflammation. At a key summit, it will pitch its unique approach for cancer, obesity, and Alzheimer's.

Monjur's new AI platform, supervised by attorneys, promises to speed up deals and cut legal risks for Managed Service Providers.

French giant Efor deepens its North American footprint, acquiring CQV specialist DynamixE to target the complex cell and gene therapy manufacturing market.

After a major turnaround, Genetix Biotherapeutics announces its first profitable quarter and plans to double production of its high-stakes gene therapies.

The EHR vendor will showcase how its 'intelligent interoperability' uses AI and patient control to move beyond compliance and create strategic advantages.

Texans Credit Union merges with Las Colinas Federal Credit Union, adding 10,000 members and expanding its footprint in a competitive North Texas market.

The Advertising Research Foundation marks 90 years by tackling AI's impact on media, reaffirming its mission to ground innovation in scientific trust.

A breakthrough quantum algorithm could shatter global encryption years ahead of schedule, forcing an urgent race to secure our digital world from a new threat.

Regulatory delays in China scuttled Pulmatrix's merger with Cullgen, forcing the biotech to urgently seek new partners for its promising drug pipeline.

As AI reshapes medicine, Seoul prepares to host global experts to explore its vast potential and critical challenges in healthcare and medical tourism.

With a $41M boost from a16z, Ease Health is using AI to unify a fractured behavioral health system, promising relief for overwhelmed providers.

Avenacy launches its 26th product, a generic Benadryl injection, tackling drug shortages and aiming to improve patient safety with unique packaging.

After a dramatic pivot and massive fundraising, Galecto will detail its new hematology pipeline at a key conference. Here’s what investors are watching.

A new era in hearing arrives with Cochlear's Nexa System, the world's first upgradeable implant, tackling India's vast auditory health challenges.